1. Home
  2. News
  3. Beijing Tiantan Biological Products Corporation Limited
  4. Announcement on Convening the Q3 2024 Performance Briefing
More Beijing Tiantan Biological Products Corporation Limited news
Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

Announcement on Convening the Q3 2024 Performance Briefing

Nov 1, 2024 · Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Nov 1, 2024 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-46

Beijing Tiantan Biological Products Corporation Limited on 6ix

Earlier from Beijing Tiantan Biological Products

  • Report for Q3 2024Oct 26, 2024
  • Announcement on the Progress of Chengdu Rongsheng Pharmaceuticals Co., Ltd. Acquiring 100% Equity of Wuhan Zhongyuan Ruide Biological Products Co., Ltd.Oct 22, 2024

Later from Beijing Tiantan Biological Products

  • Announcement on Obtaining Clinical Trial Summary Report by Affiliated EnterpriseNov 23, 2024
  • Announcement on Resignation of DirectorNov 26, 2024
  • Announcement on Resignation of Deputy General Manager and Secretary of the Board of DirectorsNov 29, 2024
  • Announcement on Resolutions of 17th Meeting of 9th Board of DirectorsDec 19, 2024
  • Announcement on Resignation of Senior OfficerDec 21, 2024
All Beijing Tiantan Biological Products news releases↗

Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.

Follow Beijing Tiantan Biological Products
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer